Literature DB >> 8036041

Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected.

D R Martin1, L M Voss, S J Walker, D Lennon.   

Abstract

Annual specific rates for acute rheumatic fever (ARF) in Auckland children less than 15 years were 22/100,000 for the years 1980 to 1984. From 1984 to 1992 the rates remained relatively constant with an average of 45 (range, 30 to 70) children annually admitted with ARF to the Auckland Children's Hospital. This study examined retrospectively Group A streptococci identified from hospitalized pediatric patients during these 9 years. The total of 2410 isolates included 32 isolates from well-documented cases of ARF and an additional 6 from siblings of cases. Results of M typing indicated that streptococci associated with ARF are generally different from those described overseas and involved types which cause more skin than throat infections in the community.

Entities:  

Mesh:

Year:  1994        PMID: 8036041     DOI: 10.1097/00006454-199404000-00004

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Authors:  E R Brandt; T Teh; W A Relf; R I Hobb; M F Good
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  M protein gene type distribution among group A streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000, and Durango, Mexico, from 1998 to 1999: overlap with type distribution within the United States.

Authors:  Luz Elena Espinosa; Zhongya Li; Demostenes Gomez Barreto; Ernesto Calderon Jaimes; Romeo S Rodriguez; Varja Sakota; Richard R Facklam; Bernard Beall
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 3.  Rheumatic fever and its management.

Authors:  Antoinette M Cilliers
Journal:  BMJ       Date:  2006-12-02

Review 4.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

5.  M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns.

Authors:  Wezenet Tewodros; Göran Kronvall
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Vaccine strategies to prevent rheumatic fever.

Authors:  E R Brandt; M F Good
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

7.  Two novel superantigens found in both group A and group C Streptococcus.

Authors:  Thomas Proft; Phillip D Webb; Vanessa Handley; John D Fraser
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.

Authors:  S Le Hello; A Doloy; F Baumann; N Roques; P Coudene; B Rouchon; F Lacassin; A Bouvet
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

9.  Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not.

Authors:  Andrew C Steer; Suzanna Vidmar; Roselyn Ritika; Joseph Kado; Michael Batzloff; Adam W J Jenney; John B Carlin; Jonathan R Carapetis
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

10.  A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia.

Authors:  Ross M Andrews; Therese Kearns; Christine Connors; Colin Parker; Kylie Carville; Bart J Currie; Jonathan R Carapetis
Journal:  PLoS Negl Trop Dis       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.